BIO’s John Crowley on RFK Jr. and tariffs, plus calls for more federal biotech funding
On The Readout LOUD podcast, STAT reporters talked with BIO's CEO John Crowley about RFK Jr. and tariffs, and discussed calls for more federal funds for biotech.
Is there more funding coming for the biotech industry? Will the pharmaceutical industry be hit with tariffs? And is it possible to reason with RFK Jr.?
We talk about all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. John Crowley, the CEO of industry lobbying group BIO, joins us to discuss the layoffs at the Food and Drug Administration, RFK Jr.’s comments on Novavax’s Covid-19 vaccine, and how the trade group is communicating with the Trump administration.
